Roche: launch of Elecsys EBV test panel
(CercleFinance.com) - Roche today announced the launch of its Elecsys EBV panel in countries accepting the CE mark.
The Elecsys EBV test panel consists of three immunoassays: Elecsys EBV IgM, Elecsys EBV VCA IgG and Elecsys EBV EBNA IgG, which detect antibodies specific to the Epstein-Barr virus (EBV) at different stages of infection. When used together, the three tests can help define how far a patient's infection has progressed.
"The launch of the Elecsys EBV panel is an important step for the diagnosis of infections in transplant patients as it gives clear and accurate results from a single sample", said Thomas Schinecker, CEO Roche Diagnostics.
Roche will apply for FDA approval in the future.
Copyright (c) 2021 CercleFinance.com. All rights reserved.
The Elecsys EBV test panel consists of three immunoassays: Elecsys EBV IgM, Elecsys EBV VCA IgG and Elecsys EBV EBNA IgG, which detect antibodies specific to the Epstein-Barr virus (EBV) at different stages of infection. When used together, the three tests can help define how far a patient's infection has progressed.
"The launch of the Elecsys EBV panel is an important step for the diagnosis of infections in transplant patients as it gives clear and accurate results from a single sample", said Thomas Schinecker, CEO Roche Diagnostics.
Roche will apply for FDA approval in the future.
Copyright (c) 2021 CercleFinance.com. All rights reserved.